Enzyme inhibitors have long been integral to therapeutic strategies, particularly in the treatment of various diseases like cancer, infectious diseases, and autoimmune disorders. However, the emergence of drug resistance has posed a significant challenge to the efficacy of many treatments. Enzyme inhibitors, which work by blocking the action of specific enzymes critical for disease progression, are now being explored as potential solutions to overcome these therapeutic obstacles.
